<DOC>
	<DOC>NCT01682486</DOC>
	<brief_summary>The objective of the study is to determine Bactiguard coated BIP Endotracheal tubeÂ´s tolerability, safety and performance and compare it to a standard un-coated Endotracheal tube.</brief_summary>
	<brief_title>BIP ETT Clinical Tolerability, Safety and Performance Study</brief_title>
	<detailed_description />
	<mesh_term>Cross Infection</mesh_term>
	<criteria>adult men and women &gt;=18 years of age are, in opinion of the investigator able to communicate with and understand the trial personnel and comply with the requirements of the trial (e.g. fill in questionnaire) requiring endotracheal intubation &gt;=3 h for elective surgery of upper gastrointestinal tract with a tube size of 7 or 8 has signed informed consent known transmissive blood disease known multiresistant bacterial colonization current and continuous treatment by immunomodulating therapies e.g. systemic (or inhalation) use of cortisone or NSAIDS ongoing respiratory infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Medical device</keyword>
	<keyword>Endotracheal Tube(s), ETT</keyword>
	<keyword>Bactiguard Coated ETT</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Safety</keyword>
	<keyword>Performance</keyword>
	<keyword>Bacterial colonization on ETT surface</keyword>
	<keyword>Hospital Acquired Infections, HAI</keyword>
	<keyword>Ventilator Associated Pneumonia, VAP</keyword>
</DOC>